Smoke-free products, like ZYN, play a critical role in helping CTP achieve this mission and provide adults who smoke with important information to guide their choices and a real opportunity to change. The full-day meeting on January 22 was part of the FDAs scientific review of PMI-affiliate Swedish Match USA Inc.s application to use the following proposed reduced risk claim: Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis. In their presentation to the committee, The FDA stated : The evidence suggests the proposed modified risk claim is scientifically accurate. Additionally, the FDA noted: Youth nicotine pouch use prevalence is currently relatively low and among young adults, viewing the proposed claim did not increase intentions to use ZYN. During the meeting, PMI experts presented data showing that exposure to the claim raised awareness that switching from cigarettes to ZYN lowers the risks of developing the six critical health conditions in the claim (i.e., mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis)
Where innovation meets reduced risk potential By heating rather than burning tobacco, Ploom AURA produces overall lower levels of harmful substances compared to cigarette smoke.* That's why Ploom AURA and the unique technology it contains aren't simply change for its own sake
Brady said he has not ethical problems with growing tobacco
Dem steht ein aktuelles KGV von 8,3 (2025e) bzw
